Niveau 2 · Kontrolleret studieRandomiseret kontrolleret studie

Changes in mineral status are associated with improvements in insulin sensitivity in obese patients following L-arginine supplementation

Suliburska J, Bogdanski P, Szulinska M, Pupek-Musialik D, Jablecka A

European journal of nutrition · 25. maj 2013

FORFATTERNES RESUMÉ

Purpose : The aim of this study is to evaluate the long-term influence of L-arginine intake on mineral concentration in patients with obesity and to assess the changes in lipid serum levels, fat content, and insulin resistance that result.

Methods : A randomized double-blind placebo-controlled study was conducted. 88 obese patients were randomly assigned to receive either 9 g of L-arginine or placebo daily, for 6 months. At baseline and after 6 months, selected anthropometrical measurements and blood biochemical analyses were performed and mineral levels were assessed. To assess insulin sensitivity, the gold-standard euglycemic clamp methodology was used.

Results : We found that 6 months of L-arginine supplementation resulted in significant increases in insulin sensitivity (Δ1.1 mg/kg/min, P < 0.01) and zinc levels (Δ1.5 μmol/L, P < 0.001). Moreover, a positive correlation between the change in zinc concentration in serum and the change in insulin sensitivity was observed (R = 0.80, P < 0.01). In the group of patients treated with L-arginine, a negative correlation between the change in zinc concentration in serum and the change in body fat content was noted (R = -0.38, P < 0.05).

Conclusions : L-Arginine supplementation affects zinc status in obese patients. One beneficial influence is related to the improvements in insulin sensitivity.

Oprindeligt resumé, gengivet uden ændringer. © Forfatterne, udbredt under en Creative Commons CC BY-licens. De nøjagtige vilkår fremgår af den oprindelige artikel.

Videnskabelig information; den erstatter ikke rådgivning fra en sundhedsperson. At et studie findes i biblioteket, udgør ikke en anprisning af vores produkter.

← Alle studier